Ask Warren

HLB

028300 · KOSDAQ · ₩028300 · HLB

₩40,000▲ ₩300 (0.76%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy

HLB028300· Biotech & PharmaUpdate note

HLB Outlines Group Mid-to-Long-Term Strategy After FDA Approval News; Financials Unchanged

HLB's group leadership presented a mid-to-long-term strategy at an IR event, and press reports quote management expecting a liver cancer drug decision within the year. This does not change the filed financials, which still show heavy losses, so our earlier cautious reading stands.

Oct 20, 20260 views

Read the research report

Report history

  1. Oct 20, 2026Update noteNewsHLB Outlines Group Mid-to-Long-Term Strategy After FDA Approval News; Financials Unchanged
  2. Oct 13, 2026InitiationHLB: Shares Up Sharply Over Three Months While Filed Results Still Show Large Losses

This is not financial advice. The report does not recommend buying or selling anything.

Also known as: HLB / 028300 / KRX:028300

Source: KRX statistical information